21 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Request for Proposals: Funding Opportunities for Kennedy’s Disease Research
The Kennedy’s Disease Association (KDA) is planning to fund one or more research grants this fall to further the understanding of the pathological mechanisms of Kennedy’s Disease.
The KDA projects that funding for each grant will be up to $25,000.
Applications from junior investigators and from senior post-doctoral fellows are encouraged.
Your proposals must be received by Friday, June 21, 2013.
ALS Therapy Alliance Grants Program
Thank you for your interest in submitting a proposal for grant funding to the ALS Therapy Alliance (ATA). Our organization traditionally awards grants from one to three years in term ranging from $100,000 to $1 million in funding to both non- and for-profit companies. National and international companies are eligible to apply.
The following outline will help you prepare the information needed for our next funding review, which happens twice a year in April and November.
Please note grant submission deadlines and number of copies requested in order to ensure timely processing of your application. The ALS Therapy Alliance does not cover indirect costs.
If you have questions about the submission process or this application, please contact Ray Bisson, Grants Manager at (603) 664-5005 or ray@alstherapyalliance.org, or visit our FAQ page.
http://alstherapyalliance.org/index.php/research/grant-submission-process/faqs.html
What to include with your grant proposal
ATA grant applications should follow the following format and adhere strictly to the maximum page limits (using only 11 point font or greater):
■ Abstract (1 page)
■ Background and Significance (2 pages)
■ Preliminary Data (2 pages)
■ Experimental Plan (3 pages)
■ References (no limit)
■ Budget
■ Budget Justification
■ NIH Biosketch (including present and pending support, 4 pages maximum) for PI's, post-docs and others involved in the project (excluding laboratory technicians)
■ Letters of collaboration and support
Grant proposal submission deadlines
To have your grant proposal reviewed at our April meeting, please submit by March 15th. To have your grant proposal reviewed at our November meeting, please submit by October 15th.
Where to send your grant proposal
Please email your proposal in PDF format to ray@alstherapyalliance.org.
Request for Application: A-T Children's Project
Attention Researchers:
Request for Application (RFA) for March 1, 2013 and September 1, 2013
Seed funding is now available for innovative proposals that seek to identify and validate biomarkers of A-T disease progression and that can be used to monitor therapeutic efficacy in clinical trials.
Please note that investigator-initiated proposals are also welcome for the March 1 and September 1 grant submission deadlines; however priority will be given to proposals that address the above referenced RFA.
We welcome investigators to contact Cynthia Rothblum-Oviatt, PhD, our Science Coordinator, if help is needed forming collaborations and/or obtaining reagents for A-T/ATM research.
Cynthia Rothblum-Oviatt, PhD Science Coordinator A-T Children's Project 5300 W. Hillsboro Blvd., Suite 105 Coconut Creek, FL 33073 cynthia@atcp.org Phone: 703-765-1223
Request for Proposals: Phase II Clinical Development of Novel, High-Potential Treatments for People with ALS
Letter of intent due: May 20, 2013
Submit letter of intent to researchgrants@alsa-national.org
The Massachusetts General Hospital Neurological Clinical Research Institute (NCRI) and The ALS Association are pleased to announce a call for phase II clinical trial applications for novel, high-potential treatments in Amyotrophic Lateral Sclerosis. The call for clinical study proposals is intended for academic-industry partnerships, including pharmaceutical, biotherapeutic/biotechnology companies, academic members of the Northeast ALS Consortium (NEALS), and ALS scientists throughout the world. A total of USD $800,000 (direct costs only) in NCRI/ALS Association clinical research support is available.
Potential Phase II clinical trials should include interventions that have:
A. a pharmacodynamics marker that can measure whether pathway of interest has been affected, and
B. a plan to collect samples for biomarker studies.
Applications will be reviewed by a joint NCRI and ALS Association steering committee and will be judged on:
-- Scientific rationale and merit, novelty, and the value of the project.
-- Availability of appropriate facilities and the technical ability to carry out the clinical study.
Funds will be awarded in the form of infrastucure support provided by NEALS and its Coordination Center, the NCRI, and funds for per subject fee, sample collection, pharmacodynamic marker testing and other trial related costs as needed. Applicants may apply for a combination of any of the following clinical research support services available through NEALS and the NCRI:
-- Project Management
-- Grants & Contracts Management
-- Data Management
-- Study Monitoring
-- Outcome Measure Development and Training
-- Biostatistical Support
-- Site Selection, Start Up, Regulatory Document Review, and Ongoing Site Management -- Site Trainings: Good Clinical Practice, Regulatory Compliance, and Site Management
The successful applicant will retain control of the trial as well as intellectual property relating to the therapeutic agent being investigated. The NCRI and The ALS Association are extremely well-positioned to work with both academic and industry partners to rapidly bring the best ALS science into clinical testing. Since infrastructure support is provided by this grant, applicants are required to contact NEALS/ALS Association prior to their grant submission to collaborate on the budget portion. Applicants may request the full $800,000 in NCRI/ALS Association research support or may request a smaller amount, depending on the appropriate needs of the proposed study.
Deadlines:
Letter of Intent: May 20, 2013
Notification to submit full application June 20, 2013
Full Application: August 15, 2013
Recipients Announced: October 2013
Award Starts: November 2013
Clinician-Scientist Development Three-Year Award in Parkinson's Disease
Co-sponsored by the American Brain Foundation and the Parkinson's Disease Foundation
Application Deadline: October 1, 2013
The American Brain Foundation, the foundation of the American Academy of Neurology, and the Parkinson’s Disease Foundation are pleased to announce a three-year Clinician-Scientist Development Award to support a clinician scientist’s research related to Parkinson’s Disease.
The three-year award will consist of an annual salary of $75,000 plus $5,000 in educational expenses, per year. Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.
ELIGIBILITY
1. Must be a neurologist interested in an academic career in clinical research.* Applicants must hold an MD, DO, or equivalent clinical degree from an accredited institution, and must be licensed to practice medicine in the United States.
2. Applicants must have completed residency training but be less than seven years from completion of residency when funding begins.
3. There is no citizenship requirement; however, the individual applying for the award must be licensed to practice medicine in the United States at the time of application.
Clinical research is defined as ”patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological disease.
For More Information
Kristin Roehl
Grants Program Manager kroehl@aan.com (612) 928-6082
Clinician-Scientist Development Award in Multiple Sclerosis
Co-sponsored by the American Brain Foundation and the National MS Society
Application Deadline: August 15, 2013
Funding Start Date: July 1, 2014
The American Brain Foundation, the foundation of the American Academy of Neurology, and the National MS Society are pleased to announce a 3-year award to support the training of young physicians committed to a career in academic medicine in an environment where problems in multiple sclerosis are addressed with the most current scientific tools. The salary is approximately $75,000/year (stipend from National MS Society based on postgraduate level plus $25,000 from the American Brain Foundation). We invite our outstanding senior residents to develop a clinically-relevant project at a US institution with a mentor who has experience in MS research.
There is no citizenship requirement, but applicants must hold an MD, DO, or equivalent degree, be at the PGY4 or PGY5 stage of an accredited residency program in the US, and hold a US medical license. Potential applicants must contact the National MS Society to confirm eligibility.
APPLICATION PROCESS
To submit a proposal for research support, investigators must first register with our apply online site, www.mssocietyapplyonline.org, and complete a pre-application, which will be reviewed to determine whether the research plan is appropriate and relevant to the award goals.
EVALUATION PROCESS
Applications are reviewed by the National MS Society Fellowship Advisory Committee and the American Brain Foundation Research Council and must be approved by both. A telephone interview is required. Evaluation criteria include the potential for the trainee to develop into a productive physician scientist, the strength of the training environment and training plan, and the quality of the research proposal.
Additional details about this training award can be found at: www.nationalmssociety.org/researchfunding
If you are interested in applying for the National MS Society – American Brain Foundation MS Clinician-Scientist Development Award or have any questions about the program, please contact:
Jennifer Stark, PhD Director of Research Training Programs National Multiple Sclerosis Society Phone: (212) 476-0462 Email: jennifer.stark@nmss.org
Clinician-Scientist Development Three-Year Award in Myasthenia Gravis and Related Disorders of the Neuromuscular Junction
Cosponsored by the American Brain Foundation and the Myasthenia Gravis Foundation of America
The American Brain Foundation, the foundation of the American Academy of Neurology, and the Myasthenia Gravis Foundation of America are pleased to announce a three-year Clinician-Scientist Development Award to support a clinician scientist’s research related to myasthenia gravis. The award aims to recognize the importance of good clinical research and encourage young investigators in clinical studies.
The three-year award will consist of an annual salary of $75,000 plus $5,000 in educational expenses, per year.
Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.
1. For the purpose of this fellowship, clinical research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue also are encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
2. Applicant must be an AAN member interested in an academic career in clinical research who has completed residency, fellowship, or a post-doctoral fellowship (for a PhD) within the past five years. Those early in their clinical research careers will be given priority.
Clinical Research Training Fellowship in Ataxia
Sponsored by the American Brain Foundation and the National Ataxia Foundation
The American Brain Foundation, the foundation of the American Academy of Neurology, is pleased to announce a two-year fellowship to support clinical research training in the field of ataxia. The fellowship is supported by the American Brain Foundation and the National Ataxia Foundation. Each fellowship will consist of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere. Supplementation of the stipend with other grants or by the fellowship institution is permissible, but fellows may not accept other fellowships, similar awards, or have another source of support for more than 50 percent of their research salary during the first year of an American Brain Foundation Clinical Research Training Fellowship. If similar awards are obtained after completion of the first year of the American Brain Foundation Clinical Research Training Fellowship, fellows are required to submit a revised budget for review by executive members of the American Brain Foundation Research Committee or may need to forfeit the rest of the American Brain Foundation award. Only direct costs will be funded by this award.
Call for Applications: Benign Essential Blepharospasm Research Foundation Fellowship Program
Blepharospasm, a form of focal dystonia, is a chronic, unremitting, bilateral, forcible closure of the eyelids. Sometimes the spasms that start in the eyelid muscles extend further down into the lower face, causing uncontrolled contractions of the jaw or tongue. This condition is called oromandibular dystonia (Meige Syndrome).
Blepharospasm is a rare disease with the incidence from 1 in 10,000 to 1 in 25,000, but it is related to other adult onset focal dystonias such as cervical dystonia (spasmodic torticollis), spasmodic dysphonia and focal hand dystonia (such as writer's and musician's cramp). Physicians and scientists who are knowledgeable about these conditions are needed and a fellowship training program will address this need by training and encouraging young investigators.
The Benign Essential Blepharospasm Research Foundation (BEBRF) is pleased to offer a research fellowship to support the training of exceptionally qualified physicians or scientists who wish to focus on blepharospasm with and without oromandibular dystonia. Fellowships will be awarded in the amount of up to $75,000 per year for two years. The training program should focus on research into new treatments, pathophysiology or the genetics of benign essential blepharospasm and oromandibular dystonia. Research into photophobia, dry eye, and apraxia of the eyelid opening as they relate to benign essential blepharospasm and oromandibular dystonia will also be considered for funding. Involvement in the activities of the Dystonia Coalition and participation in one or more annual BEBRF Symposiums will also be required.
Physician applicants must be board certified or board eligible in neurology or ophthalmology, have completed a residency, and hold or be able to hold an unrestricted license to practice medicine in the United States. PhDs should have completed their degree. Applicants will need to describe their research plans in detail, and clinicians will need to describe their clinical training as well. Applicants must select a mentor at an institution who will be willing to sponsor the applicant and will help develop a training program for the fellow. The institution must provide information on their training environment, program curriculum, and available resources. Non-U.S. citizens working at institutions either in the USA or abroad are also eligible to apply for a fellowship.
Deadline to apply for this year's fellowship is June 30, 2013 for a fellowship to begin approximately on July 1, 2014. Decisions will be announced on August 31, 2013. Applications must be submitted via e-mail to bebrf@blepharospasm.org.
123next
